Login

BlackRock Favors Japan Stocks | Hiroyuki Shimizu, CEO, BlackRock Japan Co. Ltd 00:10:00

Share On Facebook Share On Twitter

Hiroyuki Shimizu is the CEO of BlackRock Japan Co. Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Ion Energy Expands Exploration Efforts and Reports Positive Lithium Grades in Mongolia
00:10:00
Exploring India's Private Credit Market | Rishi Kapoor, CO-CEO, Investcorp Inc.
00:10:00
CECO Environmental CEO Discusses Company's Global Impact on Nasdaq | Todd Gleason - CEO of ceco environmental corp
00:10:00
In-Depth C-Suite Interview with ACCO Brands CEO Boris Elisman | Boris Elisman, CEO , ACCO Brand.
00:10:00
Geoffrey Benic, CEO of Aleafia Health Inc., and Louis Laflamme, CEO of Opsens Inc., share insights in "The View From The C-Suite."
00:10:00
Webinar Transcript on Total Cost of Ownership of Data Estates
00:10:00
GGV Capital Asia Rebrands as Granite Asia, fortifying its mission to fuel purposeful growth of the region|Jixun Foo,Senior Managing Partner, Granite Asia
00:10:00
Enriching Communities: Malakoff's Sustainability Journey and CSR Initiatives | Anwar Syahrin Bin Abdul Ajib, CEO, Malakoff Corp Bhd.
00:10:00
Cordoba Minerals: Advancing Copper-Gold-Silver Projects with Strong Backing and Strategic Exploration
00:10:00
Gene McManus: Holistic Financial Planning for a Fulfilling Life
00:10:00
Current Market Volatility: Investor Strategies | David Hefty - CHIEF EXECUTIVE OFFICER of Credent Wealth Management

© 2017 - Neuhu+